Email updates

Keep up to date with the latest news and content from BMC Psychiatry and BioMed Central.

Download references

Open Access Highly Accessed

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Alan G Wade*, Gordon M Crawford and Ann Yellowlees

BMC Psychiatry 2011, 11:42  doi:10.1186/1471-244X-11-42

Include


Format